Cargando…

Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial

Vaginal progesterone has a potential beneficial effect in postponing of preterm labor by suppression of prostaglandins cascades. Although different studies evaluated the use of progesterone for preterm birth, the exact effect of which on prolongation of pregnancy remains unclear. Seventy two women w...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh Gargari, Soraya, Habibolahi, Malihe, Zonobi, Zahra, Khani, Zahra, Sarfjoo, Fatemeh Sadat, Kazemi Robati, Atefeh, Etemad, Roja, Karimi, Zohreh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366248/
https://www.ncbi.nlm.nih.gov/pubmed/22685670
http://dx.doi.org/10.5402/2012/607906
_version_ 1782234727761051648
author Saleh Gargari, Soraya
Habibolahi, Malihe
Zonobi, Zahra
Khani, Zahra
Sarfjoo, Fatemeh Sadat
Kazemi Robati, Atefeh
Etemad, Roja
Karimi, Zohreh
author_facet Saleh Gargari, Soraya
Habibolahi, Malihe
Zonobi, Zahra
Khani, Zahra
Sarfjoo, Fatemeh Sadat
Kazemi Robati, Atefeh
Etemad, Roja
Karimi, Zohreh
author_sort Saleh Gargari, Soraya
collection PubMed
description Vaginal progesterone has a potential beneficial effect in postponing of preterm labor by suppression of prostaglandins cascades. Although different studies evaluated the use of progesterone for preterm birth, the exact effect of which on prolongation of pregnancy remains unclear. Seventy two women who underwent preterm labor were managed by magnesium sulfate. Then they were randomly assigned to continue pregnancy either by applying vaginal progesterone (400 mg) until delivery or without using any drug. Gestational age mean at the time of delivery (P = 0.039) and postponing delivery mean time (P = 0.048) were significantly higher in progesterone group. Comparison of neonatal outcomes between two groups of patients showed meaningful benefits of progesterone in increasing of neonatal weight, reduction of low birth weight babies, and lowing neonate admitted in NICU.
format Online
Article
Text
id pubmed-3366248
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-33662482012-06-08 Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial Saleh Gargari, Soraya Habibolahi, Malihe Zonobi, Zahra Khani, Zahra Sarfjoo, Fatemeh Sadat Kazemi Robati, Atefeh Etemad, Roja Karimi, Zohreh ISRN Obstet Gynecol Research Article Vaginal progesterone has a potential beneficial effect in postponing of preterm labor by suppression of prostaglandins cascades. Although different studies evaluated the use of progesterone for preterm birth, the exact effect of which on prolongation of pregnancy remains unclear. Seventy two women who underwent preterm labor were managed by magnesium sulfate. Then they were randomly assigned to continue pregnancy either by applying vaginal progesterone (400 mg) until delivery or without using any drug. Gestational age mean at the time of delivery (P = 0.039) and postponing delivery mean time (P = 0.048) were significantly higher in progesterone group. Comparison of neonatal outcomes between two groups of patients showed meaningful benefits of progesterone in increasing of neonatal weight, reduction of low birth weight babies, and lowing neonate admitted in NICU. International Scholarly Research Network 2012-05-23 /pmc/articles/PMC3366248/ /pubmed/22685670 http://dx.doi.org/10.5402/2012/607906 Text en Copyright © 2012 Soraya Saleh Gargari et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Saleh Gargari, Soraya
Habibolahi, Malihe
Zonobi, Zahra
Khani, Zahra
Sarfjoo, Fatemeh Sadat
Kazemi Robati, Atefeh
Etemad, Roja
Karimi, Zohreh
Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title_full Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title_fullStr Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title_full_unstemmed Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title_short Outcome of Vaginal Progesterone as a Tocolytic Agent: Randomized Clinical Trial
title_sort outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366248/
https://www.ncbi.nlm.nih.gov/pubmed/22685670
http://dx.doi.org/10.5402/2012/607906
work_keys_str_mv AT salehgargarisoraya outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT habibolahimalihe outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT zonobizahra outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT khanizahra outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT sarfjoofatemehsadat outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT kazemirobatiatefeh outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT etemadroja outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial
AT karimizohreh outcomeofvaginalprogesteroneasatocolyticagentrandomizedclinicaltrial